Search by keywords: and/or Category Human Oncology & Pathogenesis Program-Joint Appointees [11] 30 Faculty members found Human Oncology & Pathogenesis Program A. Ari Hakimi, MD Physician-Scientist A. Ari Hakimi, MD studies genetic and metabolic mechanisms of immune response in kidney cancers. View Publications [email protected] Human Oncology & Pathogenesis Program Adrienne A. Boire, MD, PhD Physician-scientist Adrienne Boire studies metastasis to the central nervous system. View Publications Human Oncology & Pathogenesis Program Andrew M. Intlekofer, MD, PhD Physician-scientist Andrew Intlekofer investigates why cancer cells depend on specific pathways of nutrient metabolism. View Publications Human Oncology & Pathogenesis Program Andy Minn, MD, PhD The Minn Lab investigates how cancers evolve under chronic inflammation and persistent immune pressure to acquire resistance to immunotherapies, with the goal of developing innovative therapies to restore anti-tumor immunity. View Publications Human Oncology & Pathogenesis Program Asmin Tulpule, MD, PhD The Tulpule lab studies how cells compartmentalize critical cellular processes with a focus on biomolecular condensates in cancer. View Publications [email protected] Human Oncology & Pathogenesis Program Charles L. Sawyers, MD Human Oncology and Pathogenesis Program Chair Charles Sawyers develops molecularly targeted cancer therapy. View Publications [email protected] Memorial Hospital Research Laboratories Christine A. Iacobuzio-Donahue, MD, PhD Physician-scientist Christine Iacobuzio-Donahue studies the genomics and cell biology of pancreatic and other solid tumors as it relates to subclonal evolution, tumor progression, and metastasis. View Publications Immuno-Oncology Program Chrysothemis Brown, MD, PhD The Brown Lab studies how the tissue environment shapes immune cell fate and function during early life immune development, inflammation, and cancer. View Publications Human Oncology & Pathogenesis Program David B. Solit, MD Physician-scientist David Solit studies human oncology and pathogenesis, genomics, oncogenes and tumor suppressors, cancer therapeutics, and clinical trials. View Publications [email protected] Human Oncology & Pathogenesis Program Emily H. Cheng, MD, PhD Physician-scientist Emily Cheng studies the molecular mechanisms of cell death and their implications in tumorigenesis, tumor-microenvironment interactions, targeted therapy, and immunotherapy. View Publications [email protected] Pagination Load More